MiR-301b has been shown to promote the proliferation, migration and aggressiveness of human bladder cancer cells by targeting EGR1 or through FAK and Akt phosphorylation by regulating PTEN [43, 44]. This evidence concerns the gene EGR1 and urinary bladder cancer.